AU2001273839A1 - Pharmaceutical and/or cosmetic composition containing an organosiloxane and a phospholipid - Google Patents

Pharmaceutical and/or cosmetic composition containing an organosiloxane and a phospholipid

Info

Publication number
AU2001273839A1
AU2001273839A1 AU2001273839A AU7383901A AU2001273839A1 AU 2001273839 A1 AU2001273839 A1 AU 2001273839A1 AU 2001273839 A AU2001273839 A AU 2001273839A AU 7383901 A AU7383901 A AU 7383901A AU 2001273839 A1 AU2001273839 A1 AU 2001273839A1
Authority
AU
Australia
Prior art keywords
pharmaceutical
cosmetic composition
phospholipid
organosiloxane
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001273839A
Inventor
Ralf Piotrowiak
Bernd G Seigfried
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mika Pharma Gesell fur Entwicklung und Vermarktung Pharm Prod mbH
Original Assignee
MIKA PHARMA GES fur DIE ENTWIC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MIKA PHARMA GES fur DIE ENTWIC filed Critical MIKA PHARMA GES fur DIE ENTWIC
Publication of AU2001273839A1 publication Critical patent/AU2001273839A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585—Organosilicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Abstract

Use of phospholipid in a pharmaceutical and/or cosmetic composition for use in humans, animals or plants, comprising: (i) a pharmaceutical and/or cosmetic active ingredient; and (ii) organosilicon compounds based on oligomeric and/or polymeric diorganosiloxanes, is new. Pharmaceutical and/or cosmetic composition for use in humans, animals or plants, comprises: (i) at least a pharmaceutical and/or cosmetic active ingredient; and (ii) organosilicon compounds based on oligomeric and/or polymeric diorganosiloxanes. ACTIVITY : Virucide; Fungicide; Antibacterial; Dermatological; Neurological; Antibiotic; Analgesic; Antirheumatic; Anticoagulant; Thrombolytic; Antiallergic; Immunosuppressive; Vulnerary; Relaxant; Anticonvulsant; Antiparkinsonian; Antiemetic; Cardiant; Antiasthmatic; Antitussive; Hepatotropic; Cytostatic; Immunomodulatory; Nephrotropic. No biological data given.
AU2001273839A 2000-05-19 2001-04-14 Pharmaceutical and/or cosmetic composition containing an organosiloxane and a phospholipid Abandoned AU2001273839A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10024413 2000-05-19
DE10024413A DE10024413A1 (en) 2000-05-19 2000-05-19 Pharmaceutical and / or cosmetic preparation
PCT/DE2001/001483 WO2001087344A1 (en) 2000-05-19 2001-04-14 Pharmaceutical and/or cosmetic composition containing an organosiloxane and a phospholipid

Publications (1)

Publication Number Publication Date
AU2001273839A1 true AU2001273839A1 (en) 2001-11-26

Family

ID=7642554

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001273839A Abandoned AU2001273839A1 (en) 2000-05-19 2001-04-14 Pharmaceutical and/or cosmetic composition containing an organosiloxane and a phospholipid

Country Status (12)

Country Link
US (1) US20030170194A1 (en)
EP (2) EP1282446B1 (en)
JP (1) JP2003533491A (en)
AT (2) ATE487495T1 (en)
AU (1) AU2001273839A1 (en)
CY (2) CY1107159T1 (en)
DE (3) DE10024413A1 (en)
DK (2) DK1818041T3 (en)
ES (2) ES2296758T3 (en)
PT (2) PT1282446E (en)
SI (1) SI1282446T1 (en)
WO (1) WO2001087344A1 (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10251963A1 (en) * 2002-11-08 2004-05-19 Lts Lohmann Therapie-Systeme Ag Wafer-form transmucosal dosage form, comprising solution of active agent, e.g. for combating drug abuse, in phosphatidyl choline fraction, providing both rapid and constant release via the oral cavity
FR2856301B1 (en) * 2003-06-23 2007-08-03 Galderma Res & Dev SPRAY COMPOSITION COMPRISING A PHARMACEUTICAL ACTIVE, AT LEAST ONE VOLATILE SILICONE AND A NON-VOLATILE NON-POLAR PHASE
FR2867682B1 (en) * 2004-03-22 2009-06-05 Galderma Res & Dev ANHYDROUS PHARMACEUTICAL COMPOSITION COMPRISING A SILICONE AGENT AND A SOLUBILIZED ACTIVE INGREDIENT.
FR2871700B1 (en) * 2004-06-17 2006-11-17 Galderma Sa SPRAY COMPOSITION COMPRISING AN ASSOCIATION OF PHARMACEUTICAL ASSETS, AN ALCOHOLIC PHASE, AND AN OILY PHASE
FR2871695B1 (en) * 2004-06-17 2008-07-04 Galderma Sa PHARMACEUTICAL COMPOSITION COMPRISING A SILICONE AGENT AND TWO SOLUBILIZED ACTIVE INGREDIENTS
JP2008502646A (en) * 2004-06-17 2008-01-31 ガルデルマ・ソシエテ・アノニム Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase, and an oily phase
EP1758589A1 (en) * 2004-06-17 2007-03-07 Galderma S.A. Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin d or a derivative thereof
FR2871697B1 (en) * 2004-06-17 2007-06-29 Galderma Sa SPRAY COMPOSITION COMPRISING AN ASSOCIATION OF PHARMACEUTICAL ASSETS, AN ALCOHOLIC PHASE, AT LEAST ONE VOLATILE SILICONE AND A NON-VOLATILE OIL PHASE
US20070036731A1 (en) * 2005-08-13 2007-02-15 Collegium Pharmaceutical, Inc. Topical Delivery with a Carrier Fluid
JP5371235B2 (en) * 2006-12-06 2013-12-18 ロート製薬株式会社 Topical skin preparation
EP1972324A1 (en) * 2007-03-21 2008-09-24 Cognis IP Management GmbH Encapsulated liposomes
WO2009084041A2 (en) * 2008-01-01 2009-07-09 Shasun Chemicals And Drugs Limited Pharmaceutical compositions of dexibuprofen
IL191123A0 (en) * 2008-04-28 2009-02-11 Meir Shinitzky Composition comprising phospholipids in combination with ascorbic acid and cosmetic products comprising it
SI2387391T1 (en) * 2009-07-24 2017-04-26 Mika Pharma Gesellschaft Fuer Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Method for developing a liquid composition to be applied to the skin as a foam and a composition that can be applied topically
RS63043B1 (en) * 2009-11-03 2022-04-29 Lipidor Ab Lipid layer forming composition for administration onto a surface of a living organism
JP2013510085A (en) * 2009-11-03 2013-03-21 リピドール エービー Composition for promoting wound treatment
US10045996B2 (en) 2010-03-17 2018-08-14 Novaliq Gmbh Pharmaceutical composition for treatment of increased intraocular pressure
EP2444063A1 (en) 2010-10-20 2012-04-25 Novaliq GmbH Liquid pharmaceutical compositions for the delivery of active ingredients
SE1300709A1 (en) * 2013-11-14 2015-05-15 Lipidor Ab Composition and method of topical treatment
WO2012150890A1 (en) * 2011-05-02 2012-11-08 Lipidor Ab Antibacterial composition
CA2834301A1 (en) * 2011-05-02 2012-11-08 Lipidor Ab Treatment of psoriasis
DK2714010T3 (en) 2011-05-25 2017-06-12 Novaliq Gmbh TOPICAL PHARMACEUTICAL COMPOSITION BASED ON SEMIFLUORED ALKANES
CA2997744C (en) 2012-09-12 2019-12-31 Novaliq Gmbh Compositions comprising mixtures of semifluorinated alkanes
CA3142049C (en) 2012-09-12 2023-08-29 Novaliq Gmbh Semifluorinated alkane compositions
BR112015027436A8 (en) * 2013-05-03 2018-01-16 Lipidor Ab topical composition and vehicle for administration of pharmaceutically or cosmetically active ingredients
AU2014349256B2 (en) * 2013-11-14 2020-04-30 Lipidor Ab Sprayable topical carrier and composition comprising phosphatidylcholine
EP4122460A1 (en) 2015-01-09 2023-01-25 Chase Pharmaceuticals Corporation Oxybutynin transdermal therapeutic system combination
CN110403923B (en) 2015-09-30 2021-09-21 诺瓦利克有限责任公司 Semifluorinated compounds and compositions thereof
ES2803248T3 (en) 2015-09-30 2021-01-25 Novaliq Gmbh 2-perfluorohexyl octane for ophthalmic administration
PT3442480T (en) 2016-06-23 2019-12-23 Novaliq Gmbh Topical administration method
US11684589B2 (en) 2016-09-22 2023-06-27 Novaliq Gmbh Pharmaceutical compositions for use in the therapy of blepharitis
AU2017329983B2 (en) 2016-09-23 2022-05-05 Novaliq Gmbh Ophthalmic compositions comprising ciclosporin
AU2018253944B2 (en) 2017-04-21 2022-09-15 Dermaliq Therapeutics, Inc. Iodine compositions
CN110650734A (en) 2017-05-12 2020-01-03 诺瓦利克有限责任公司 Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of conditions associated with contact lenses
MX2020003534A (en) 2017-09-27 2020-07-29 Novaliq Gmbh Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases.
WO2019068763A1 (en) 2017-10-04 2019-04-11 Novaliq Gmbh Ophthalmic compositions comprising f6h8
AU2019228119A1 (en) 2018-03-02 2020-09-10 Novaliq Gmbh Pharmaceutical compositions comprising nebivolol
EP3856128B1 (en) 2018-09-27 2023-06-07 Dermaliq Therapeutics, Inc. Topical sunscreen formulation
WO2020074697A1 (en) 2018-10-12 2020-04-16 Novaliq Gmbh Ophthalmic composition for treatment of dry eye disease

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH072631B2 (en) * 1987-03-06 1995-01-18 テルモ株式会社 Gel composition
US4783450A (en) * 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
JPH078333B2 (en) * 1987-12-28 1995-02-01 有限会社野々川商事 Oil-in-water emulsion composition and polyhydric alcohol-in-oil emulsion composition
US5489433A (en) * 1991-01-04 1996-02-06 Safe-Tee Chemical Products Company Environmentally safe insecticide
FR2679446B1 (en) * 1991-07-24 1993-10-29 Oreal METHOD FOR MANUFACTURING A COSMETIC COMPOSITION FOR APPLICATION TO HAIR, COMPOSITION OBTAINED BY THIS PROCESS AND METHOD FOR COSMETIC TREATMENT USING THE SAME.
JPH06135816A (en) * 1992-10-30 1994-05-17 Earth Chem Corp Ltd Cosmetic composition
JPH0823801B2 (en) * 1993-04-26 1996-03-06 日本電気株式会社 Disk controller
FR2709131B1 (en) * 1993-08-18 1995-11-10 Cilag Laboratoire Device for dispensing a therapeutic or cosmetic substance, the inert vehicle of which is a volatile polydiorganosiloxane, and composition intended for use in the device.
US5556280A (en) * 1994-05-31 1996-09-17 Pelak; Mark S. Method and apparatus for appliance mounting
US6045823A (en) * 1996-09-19 2000-04-04 Dragoco Gerberding & Co. Ag Process for producing solid anhydrous composition, and pharmaceutical and cosmetic products comprising same
DE19641259A1 (en) * 1996-10-07 1998-04-16 Kade Pharma Fab Gmbh Medicines based on diclofenac
FR2761912B1 (en) * 1997-04-14 1999-07-02 Capsulis PROCESS FOR ADHERING A PRODUCT TO A SURFACE
DE19804837A1 (en) * 1998-01-29 1999-08-05 Coty Bv Cosmetic product for regeneration and stimulation of skin cells
FR2777179A1 (en) * 1998-04-09 1999-10-15 Lvmh Rech Cosmetic and dermatological composition with non-greasy feel and useful as carrier
FR2777181A1 (en) * 1998-04-10 1999-10-15 Lvmh Rech Water-in-oil cosmetic composition without greasy feel and useful as carrier
BE1011899A6 (en) * 1998-04-30 2000-02-01 Ucb Sa PHARMACEUTICAL USE gelling.
DE19826503A1 (en) * 1998-06-13 1999-12-16 Beiersdorf Ag Cosmetic and dermatological preparations containing chitosan and phospholipids
IT1313595B1 (en) * 1999-08-03 2002-09-09 Giorgio Panin SPRAY DISPENSING DEVICE OF A COMPOSITION FOR TOPICAL APPLICATION INCLUDING VITAMIN AND ESSENTIAL FATTY ACIDS.

Also Published As

Publication number Publication date
SI1282446T1 (en) 2008-04-30
PT1282446E (en) 2007-12-21
ATE487495T1 (en) 2010-11-15
DK1818041T3 (en) 2011-02-28
DE50115705D1 (en) 2010-12-23
ES2352222T3 (en) 2011-02-16
WO2001087344A1 (en) 2001-11-22
US20030170194A1 (en) 2003-09-11
CY1107159T1 (en) 2012-10-24
EP1818041A2 (en) 2007-08-15
EP1818041B1 (en) 2010-11-10
CY1111533T1 (en) 2015-08-05
ATE380036T1 (en) 2007-12-15
DE10024413A1 (en) 2001-12-06
EP1282446B1 (en) 2007-12-05
EP1818041A3 (en) 2007-09-19
PT1818041E (en) 2010-12-28
ES2296758T3 (en) 2008-05-01
DK1282446T3 (en) 2008-01-02
JP2003533491A (en) 2003-11-11
EP1282446A1 (en) 2003-02-12
DE50113348D1 (en) 2008-01-17

Similar Documents

Publication Publication Date Title
AU2001273839A1 (en) Pharmaceutical and/or cosmetic composition containing an organosiloxane and a phospholipid
AU2807195A (en) Hair growing agent
EP2145614A3 (en) Non-irritating moisturizing or skin care composition comprising an antimicrobial agent and an emollient
EP1576963A3 (en) Use of botulinum toxin in the treatment of pain due to an infection
AU2845599A (en) Pharmaceutical compositions and their use
PT806941E (en) LIPOSOMIC ANTI-BACTERIAL COMPOSITIONS OF LOW RIGIDITY
AU6628496A (en) Polyether block copolymer micellar compositions for targeting biological agents
EP0595133A3 (en) Prodrugs, their preparation and use as medicaments
AU6456996A (en) Polymeric drug formulations
AU6818196A (en) Substituted 2,4-imidazolidinedione compounds as pharmaceutical active ingredients
MX9804226A (en) Novel 2,3,5-trimethyl-4-hydroxy anilide derivatives, preparation thereof and therapeutical use thereof.
TR199900661T2 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
KR970706253A (en) INDOLE-2-CARBOXYLIC ESTER DERIVATIVES AND AGRICULTURAL AND HORTICULTURAL BACTERIOCIDES CONTAINING THE SAME AS THE ACTIVE INGREDIENT
AU2668400A (en) Human antibiotic proteins
EP1084704A4 (en) Remedies for spinocerebellar ataxia and compositions for treating spinocerebellar ataxia
ES2170377T3 (en) COMPOSITION CONTAINING QUITOSANA.
FR2733913B1 (en) DNA SEQUENCE AS A MEDICAMENT, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
TR199701286T1 (en) Esters of carbapenems.
IT1284970B1 (en) PHARMACEUTICAL AND COSMETIC FORMULATIONS WITH ANTI-MICROBIAL ACTIVITY
UA30143C2 (en) TREATMENT FOR PREVENTION AND TREATMENT OF INFECTIOUS AND INFLAMMATORY DISEASES
GEU1999425Y (en) Medicinal Ointment “Mdivnishvili -7”
RU96114929A (en) MEANS FOR TREATMENT OF INFECTIOUS RESPIRATORY DISEASES
AU2002340731A1 (en) Phenotype-determining virulence genes of pseudomonas aeruginosa for colonization and persistence in human beings, animals and plants, uses of said gene and associated proteins
BR7502805U (en) Animal traction planter and fertilizer machine